{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:12:32Z","timestamp":1791486752419,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>This article focuses on the Triglyceride-Glucose Body Mass Index (TyG-BMI) in diabetes and its associated cardiovascular complications. It elaborates on the basic concepts, current clinical practices, technological advancements, controversies, challenges, and future directions related to TyG-BMI. By integrating the findings from numerous studies, we aimed to provide a comprehensive understanding of the role of TyG-BMI in diabetes and cardiovascular disease research, diagnosis, and treatment, highlighting its significance and potential for improving the management of diabetic cardiovascular health.<\/jats:p>","DOI":"10.3389\/fendo.2025.1675270","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:39Z","timestamp":1759119159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Understanding triglyceride glucose-body mass index: implications for diabetes and cardiovascular disease management"],"prefix":"10.3389","volume":"16","author":[{"given":"Shunping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11892-022-01453-4","article-title":"Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus","volume":"22","author":"Ortiz-Mart\u00ednez","year":"2022","journal-title":"Curr Diabetes Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e3646","DOI":"10.1097\/MD.0000000000003646","article-title":"TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain","volume":"95","author":"Navarro-Gonz\u00e1lez","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0163465","DOI":"10.1371\/journal.pone.0163465","article-title":"Predictive value of triglyceride glucose index for the risk of incident diabetes: A 4-year retrospective longitudinal study","volume":"11","author":"Lee","year":"2016","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/met.2020.0092","article-title":"Triglyceride-glucose index and related parameters predicted metabolic syndrome in Nigerians","volume":"19","author":"Raimi","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1448359","article-title":"Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study","volume":"15","author":"Huang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals","volume":"11","author":"Er","year":"2016","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-024-02275-2","article-title":"Association of triglyceride glucose index and triglyceride glucose-body mass index with sudden cardiac arrest in the general population","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12933-024-02213-2","article-title":"Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease","volume":"23","author":"Lyu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","article-title":"Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study","volume":"22","author":"Cheng","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","article-title":"Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-023-02114-w","article-title":"Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02862-3","article-title":"Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study","volume":"75","author":"Liu","year":"2022","journal-title":"Endocrine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1362667","article-title":"Association between triglyceride glucose body mass index and cardiovascular disease in adults: evidence from NHANES 2011\u20132020","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-023-01924-2","article-title":"Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk","volume":"22","author":"Cai","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1573403X314035","DOI":"10.2174\/011573403X314035241006185109","article-title":"Insulin resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects","volume":"21","author":"Papaetis","year":"2025","journal-title":"Curr Cardiol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13098-018-0383-9","article-title":"LIPC variants as genetic determinants of adiposity status, visceral adiposity indicators, and triglyceride-glucose (TyG) index-related parameters mediated by serum triglyceride levels","volume":"10","author":"Teng","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e7041","DOI":"10.1097\/MD.0000000000007041","article-title":"Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects","volume":"96","author":"Zhang","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","article-title":"Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey","volume":"14","author":"Lim","year":"2019","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2006.11.001","article-title":"Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up","volume":"18","author":"Bigazzi","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.01.008","article-title":"Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease","volume":"153","author":"Tenenbaum","year":"2007","journal-title":"Am Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762\u20134","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e328333645a","article-title":"The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review","volume":"11","author":"Reddy","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154838","article-title":"Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes","volume":"123","author":"Yun","year":"2021","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04221","article-title":"Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study","volume":"64","author":"van Sloten","year":"2014","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-020-00408-8","article-title":"Insulin resistance the hinge between hypertension and type 2 diabetes","volume":"27","author":"Mancusi","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199508001-00010","article-title":"Insulin resistance and hyperinsulinemia in hypertension","volume":"13","author":"Weidmann","year":"1995","journal-title":"J Hypertens Suppl"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319130010","article-title":"Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk","volume":"19","author":"Del Turco","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-007-0035-1","article-title":"Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation","volume":"7","author":"Boden","year":"2007","journal-title":"Curr Diabetes Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.01.006","article-title":"Coronary magnetic resonance angiography: technical innovations leading us to the promised land","volume":"13","author":"Hajhosseiny","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12872-024-03722-4","article-title":"Triglyceride glucose-body mass index as a novel predictor of slow coronary flow phenomenon in patients with ischemia and nonobstructive coronary arteries (INOCA)","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cct.2016.03.006","article-title":"Track: A randomized controlled trial of a digital health obesity treatment intervention for medically vulnerable primary care patients","volume":"48","author":"Foley","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02499-y","article-title":"Association between the triglyceride glucose-body roundness index and the incidence of cardiovascular disease among Chinese middle and old-aged adults: a nationwide prospective cohort study","author":"Bai","year":"2025","journal-title":"Acta Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e002112","DOI":"10.1161\/JAHA.115.002112","article-title":"Distribution of short-term and lifetime predicted risks of cardiovascular diseases in Peruvian adults","volume":"4","author":"Quispe","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew440","article-title":"Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis","volume":"56","author":"Alemao","year":"2017","journal-title":"Rheumatol (Oxf Engl)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01568-6","article-title":"Triglyceride glucose index-body mass index as a predictor of coronary artery disease severity in patients with H-type hypertension across different glucose metabolic states","volume":"17","author":"Wang","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1597112","article-title":"Research status of triglyceride glucose-body mass index (TyG-BMI index)","volume":"12","author":"Song","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"17687","DOI":"10.1038\/s41598-025-02342-y","article-title":"Association of body mass index combined with triglyceride-glucose index in cardiovascular disease risk: a prospective cohort study","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12933-023-02011-2","article-title":"Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1111\/1753-0407.70001","article-title":"Assessing and predicting type 2 diabetes risk with triglyceride glucose-body mass index in the Chinese nondiabetic population-Data from long-term follow-up of Da Qing IGT and Diabetes Study","volume":"16","author":"Wang","year":"2024","journal-title":"J Diabetes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1017\/S0954422421000378","article-title":"A synthesis of pathways linking diet, metabolic risk and cardiovascular disease: a framework to guide further research and approaches to evidence-based practice","volume":"36","author":"Lima do Vale","year":"2023","journal-title":"Nutr Res Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1038\/s41598-024-64784-0","article-title":"J-shaped association of the triglyceride glucose-body mass index with new-onset diabetes","volume":"14","author":"Qiao","year":"2024","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2196\/medinform.6730","article-title":"Patient similarity in prediction models based on health data: A scoping review","volume":"5","author":"Sharafoddini","year":"2017","journal-title":"JMIR Med Inform"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1675270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:40Z","timestamp":1759119160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1675270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":46,"alternative-id":["10.3389\/fendo.2025.1675270"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1675270","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1675270"}}